These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16136633)

  • 1. Cost-effective allocation of government funds to prevent HIV infection.
    Cohen DA; Wu SY; Farley TA
    Health Aff (Millwood); 2005; 24(4):915-26. PubMed ID: 16136633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Theory to Practice: Implementation of a Resource Allocation Model in Health Departments.
    Yaylali E; Farnham PG; Schneider KL; Landers SJ; Kouzouian O; Lasry A; Purcell DW; Green TA; Sansom SL
    J Public Health Manag Pract; 2016; 22(6):567-75. PubMed ID: 26352385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal investment in a portfolio of HIV prevention programs.
    Zaric GS; Brandeau ML
    Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal allocation of HIV prevention funds for state health departments.
    Yaylali E; Farnham PG; Cohen S; Purcell DW; Hauck H; Sansom SL
    PLoS One; 2018; 13(5):e0197421. PubMed ID: 29768489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users.
    Richter A; Brandeau ML; Owens DK
    Med Decis Making; 1999; 19(2):167-79. PubMed ID: 10231079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for allocating CDC's HIV prevention resources in the United States.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    Health Care Manag Sci; 2011 Mar; 14(1):115-24. PubMed ID: 21184183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis.
    Brandeau ML; Zaric GS; Richter A
    J Health Econ; 2003 Jul; 22(4):575-98. PubMed ID: 12842316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allocating HIV-prevention resources: balancing efficiency and equity.
    Kaplan EH; Merson MH
    Am J Public Health; 2002 Dec; 92(12):1905-7. PubMed ID: 12453805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis of HIV prevention interventions in Andhra Pradesh state of India to inform resource allocation.
    Dandona L; Kumar SG; Kumar GA; Dandona R
    AIDS; 2009 Jan; 23(2):233-42. PubMed ID: 19112690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying public health principles to the HIV epidemic.
    Frieden TR; Das-Douglas M; Kellerman SE; Henning KJ
    N Engl J Med; 2005 Dec; 353(22):2397-402. PubMed ID: 16319391
    [No Abstract]   [Full Text] [Related]  

  • 11. A systematic review on cost effectiveness of HIV prevention interventions in the United States.
    Huang YL; Lasry A; Hutchinson AB; Sansom SL
    Appl Health Econ Health Policy; 2015 Apr; 13(2):149-56. PubMed ID: 25536927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allocating HIV prevention funds in the United States: recommendations from an optimization model.
    Lasry A; Sansom SL; Hicks KA; Uzunangelov V
    PLoS One; 2012; 7(6):e37545. PubMed ID: 22701571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Employing resource allocation modeling to inform HIV prevention planning for the state of Iowa.
    Holtgrave DR; Young PA; Mayer RR; Maulsby C; Kim JJ
    AIDS Educ Prev; 2013 Oct; 25(5):423-9. PubMed ID: 24059879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions.
    Anderson SJ; Ghys PD; Ombam R; Hallett TB
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29220115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural interventions to prevent HIV/sexually transmitted disease: are they cost-effective for women in the southern United States?
    Cohen DA; Wu SY; Farley TA
    Sex Transm Dis; 2006 Jul; 33(7 Suppl):S46-9. PubMed ID: 16794555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining allocations for HIV-prevention interventions: assessing a change in federal funding policy.
    Valdiserri RO; Robinson C; Lin LS; West GR; Holtgrave DR
    AIDS Public Policy J; 1997; 12(4):138-48. PubMed ID: 10915267
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the impact of federal HIV prevention spending on HIV testing and awareness.
    Linas BP; Zheng H; Losina E; Walensky RP; Freedberg KA
    Am J Public Health; 2006 Jun; 96(6):1038-43. PubMed ID: 16670217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reorienting the HIV response in Niger toward sex work interventions: from better evidence to targeted and expanded practice.
    Fraser N; Kerr CC; Harouna Z; Alhousseini Z; Cheikh N; Gray R; Shattock A; Wilson DP; Haacker M; Shubber Z; Masaki E; Karamoko D; Görgens M
    J Acquir Immune Defic Syndr; 2015 Mar; 68 Suppl 2():S213-20. PubMed ID: 25723987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on funds application of community based organizations involved in HIV/AIDS response and government financial investment in China, 2014].
    Zhang G; Zhu YX; Wang P; Liu P; Li JF; Sha S; Yang WZ; Li H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):232-236. PubMed ID: 28260337
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic disease and disadvantage: the new politics of HIV infection.
    Fox DM
    J Health Polit Policy Law; 1990; 15(2):341-55. PubMed ID: 2212529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.